Introduction
============

Esophageal cancer is among the most incident malignant tumors worldwide [@B1] and a serious threat to human health and quality of life [@B2]. Esophageal squamous cell carcinoma (ESCC) is one of the two main sub-types of esophageal cancer, and ESCC is more common than esophageal adenocarcinoma in the developing world, especially in China [@B3]. The prognosis of ESCC is poor despite advances in treatment, with 5-year overall survival rate ranging from 15% to 25% [@B4],[@B5].

Accumulating evidence has demonstrated that genetic factors [@B6]-[@B10], family history of ESCC [@B11]-[@B13], lifestyle habits [@B14]-[@B16], environmental factors [@B17]-[@B23], and HPV infection [@B24] play important roles in the development of ESCC. Significant interactions were found between HPV serological status and genetic loci, increasing the risk of ESCC [@B25],[@B26]. Other risk factors such as exposure to polycyclic aromatic hydrocarbons (PAHs), high-temperature foods, diets, oral health and microbial communities, but they require further research. Esophageal carcinogenesis is the result of the interaction among heredity, environment and living habits [@B27]-[@B29].

In recent years, genome-wide association studies (GWAS) have confirmed the contribution of gene variations to ESCC [@B30]-[@B35]. Six large-scale GWAS of Chinese populations have focused on identifying genetic susceptibility loci for ESCC [@B31]-[@B35]. The earliest ESCC GWAS analysis using 2115 ESCC cases and 3302 controls in a Chinese population revealed that PLCE1 carried cancer susceptibility [@B31]. Wang *et al*. identified two new genome-wide significant loci for ESCC: PLCE1 at 10q23 and C20orf54 at 20p13 [@B32]. Seven loci on chromosomes 5q11, 6p21, 10q23, 12q24 and 21q22 were associated with the risk of ESCC [@B33]. In another GWAS in a Chinese ESCC population, Wu *et al*. [@B34] identified nine new ESCC susceptibility loci: seven (on chromosomes 4q23, 16q12.1, 17q21, 22q12, 3q27, 17p13 and 18p11) had a significant marginal effect on the risk of ESCC and two (on 2q22 and 13q33) had a significant association but only when considering the gene-alcohol interaction. Wu *et al*. identified rs1050631 in SLC39A6 as being associated with the survival of ESCC patients [@B35].

Whether those 24 SNPs found by the five GWAS confer an increased risk of ESCC in various Han Chinese populations has not yet been validated. Therefore, we conducted a case-control study to validate the associations of those 24 SNPs with the risk of ESCC in a Han Chinese subgroup from Eastern China.

Material and Methods
====================

Study population
----------------

This was a retrospective study. We included 2280 consecutive ESCC subjects and 1900 non-ESCC subjects (control group). The diagnosis of ESCC was confirmed by histopathology or cytology by at least two local pathologists. Histological examination was performed according to the World Health Organization (WHO) criteria [@B36]. The exclusion criteria for both groups were: 1) psychiatric disorder; 2) any other primary cancer; or 3) a family history of cancer. This study consisted of two ESCC sets: (a) 1900 patients with primary ESCC, and (b) 380 patients with second ESCC. The patients were recruited between January 2012 and December 2014 at Zhejiang Cancer Hospital. Demographic characteristics of the subjects (including gender, age, histological types of esophageal cancer, smoking and drinking status) were obtained from the medical records. Non-ESCC individuals (n=1900) were recruited as control subjects during a routine health check-up (physical examination) at the same hospital during the same time period. The two groups were matched based on the frequency of age and sex. In the present study, all participants were ethnic Han Chinese that lived within the Zhejiang Province of Eastern China.

SNP selection
-------------

We selected the 24 top SNPs (rs4478858, rs10881372, rs10801638, rs10173378, rs888103, rs3815501, rs6717108, rs10934685, rs6768588, rs9824873, rs6854472, rs12188136, rs2294693, rs9364414, rs7916519, rs11225815, rs10895458, rs4578395, rs11059556, rs2025245, rs9584006, rs347940, rs875339, and rs12922317) from the reports focusing on ESCC susceptibility loci identified by five GWAS projects in Han Chinese (PubMed search) [@B31]-[@B35].

SNP genotyping assays
---------------------

Venous blood (2 mL) was sampled in citrate glass tubes and kept at -40°C. Leukocyte total genomic DNA was extracted from 1 mL of peripheral blood using the Whole Blood DNA Extraction Kit (QIAamp® DNA Blood Mini Kit), according to the manufacturer\'s instructions. The extracted genomic DNA was dissolved in 0.1× TE buffer (10 mMTris and 1 mM EDTA, pH 8.0) to 0.4-0.6 mg/mL and stored at -20°C.

The SNPs were determined using iPLEX chemistry on a matrix-assisted laser desorption/ ionization time-of-flight mass spectrometer (MALDI-TOF-MS, MassARRAY system, Sequenom, Inc.), as previously published [@B37]. PCR reactions (5 μL each) were carried out in 384-well plates using 10 ng of genomic DNA, 0.5 units of Taq polymerase (HotStarTaq, Qiagen), 500 μmol of each of the four deoxynucleotides triphosphate (dNTP), and 100 nmol of each primer. An ABI-9700 thermocycler was used with the following program: 1) 15 min at 94°C; 2) 45 cycles of 20 s at 94°C, 30 s at 56°C, and 60 s at 72°C. The reaction products were separated on 2.0% agarose. After PCR, 0.3 units of shrimp alkaline phosphatase was added and incubated at 37°C for 20 min followed by inactivation for 5 min at 85°C. The concentration of the extension primers was adjusted to optimize the signal-to-noise ratio. The iPLEX Gold Kits (Sequenom, Inc.) was used to prepare the samples with 0.2 μL (100 μmol) of termination mix, 0.05 units of DNA polymerase (Sequenom, Inc.), and 625 to 1250 nmol/L extension primers. The iPLEX reaction was performed using the following program: 1) initial denaturation for 30 s at 94°C; 2) 5 s at 94°C and five cycles of 5 s at 52°C and 5 s at 80°C; 3) 40 annealing and extension cycles; 4) 5 s at 94°C; 5) five cycles of 5 s at 52°C and 5 s at 80°C; and 6) 72°C for 3 min and the sample The products were analyzed by MALDI-TOF-MS. The samples were desalted using 6 mg of resin and transferred to a 384-well Spectro-CHIP (Sequenom, Inc.). The mass spectra were acquired and analyzed using the MassARRAYTyper 4.0 Software (Sequenom, Inc.). Controls were performed without template DNA. All laboratory technicians were unaware of patient status.

Statistical analyses
--------------------

Values were expressed as means ± standard deviation (SD) or numbers. Continuous variables were analyzed using the unpaired Student\'s *t*-test. Differences in frequencies of the alleles and genotypes between case group and control group were evaluated using the χ^2^-test. Genotype distribution and allele frequencies were compared using the chi-square test. The chi-square test was also used to examine the Hardy-Weinberg Equilibrium (HWE) in the control group (*P*-value of \<0.05 was considered to be statistically significant). Akaike\'s information criteria were used to select the most parsimonious genetic model for each SNP [@B38]. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by unconditional logistic regression analysis. All analyses were conducted with Stata statistical package (version 10.0; Stata Corp LP, College Station, TX, USA). The *P* value of allele difference was conducted with chi-square test between esophageal cancer and control group. *P*-value \< 0.05 was considered statistically significant.

Results
=======

Characteristics of the subjects
-------------------------------

The demographic characteristics of the subjects are shown in Table [1](#T1){ref-type="table"}. There were no differences in age (57.0±8.8 vs. 56.4±9.3 years) or gender (male, 63.1% vs. 64.5%) between the two groups (both*P* \> 0.05).

Individual SNP association analysis
-----------------------------------

The genomic characteristics of 24 SNPs are given in Table [2](#T2){ref-type="table"}. There was no deviation from the Hardy-Weinberg equilibrium in the control group (all *P* \> 0.01). In the single-locus analyses, the allelic frequencies of rs10173378: A\>G (0.241 vs. 0.221, *P* = 0.0409) and rs6854472: G\>T (0.072 vs. 0.084, *P* = 0.0477) were slightly different between the ESCC and control group, but 100,000 permutations showed that there were no significant differences between the two groups. The genotype distributions of the 24 SNPs in the two groups are summarized in Table [3](#T3){ref-type="table"}. The distribution of the rs12188136 (47.4% vs. 50.2%, *P* = 0.0493) and rs875339 (49.4% vs. 48.4%, *P* = 0.0341) genotypes showed significant differences between the cases and controls.

Logistic regression analyses revealed that in the codominant-effect model, the ESCC risk was associated with rs12188136 (*P* = 0.027, OR = 1.158, 95% CI = 1.016-1.319 for AG/AA). Binary logistic regression analyses revealed a slight negative association of rs10895458 (*P* = 0.044, OR = 0.547, 95% CI = 0.304-0.983 for CC/AA) and a significant negative association of rs875339 (*P* = 0.014, OR = 0.762, 95% CI = 0.613-0.947 for TT/CC), but because of the rarity of the homozygous mutant genotype (\<3%), the results were invalid for rs10895458. In addition, marginal esophageal cancer risk was found for rs6854472 (*P* = 0.056, OR = 1.187, 95% CI = 0.995-1.417 for GT/GG) (Table [3](#T3){ref-type="table"}).

Using the dominant model, significant ESCC risk was observed for rs6854472 (*P* = 0.048, OR = 1.192, 95% CI = 1.002-1.418). Using the recessive model, a significant negative association was observed for rs875339 (*P* = 0.010, OR = 0.758, 95% CI = 0.615-0.935) (Table [4](#T4){ref-type="table"}).

Discussion
==========

ESCC is one of the most prevalent cancers worldwide and occurs at a relatively high frequency in China. Some recent genome-wide association studies have identified 24 single-nucleotide polymorphisms that may be associated with ESCC. This study aimed to validate the association between these 24 polymorphisms and ESCC in a Han subgroup from Eastern China. The results suggest that rs12188136 and rs6854472 are associated with ESCC in this Han Chinese subgroup, and that rs875339 is negative associated with ESCC.

This study was a large-scale study in Han Chinese patients from Eastern China that describes the association between ESCC and 24 genome-wide SNPs. Besides rs12188136 and rs6854472 localizing in intergenic areas, *RORA* could play a role in the development of ESCC [@B31]-[@B35]. Abnet *et al.* [@B31] conducted the first large-scale genome-wide association studies for ESCC using 2115 ESCC cases and 3302 controls in Chinese, and identified PLCE1 at 10q23 for ESCC susceptibility. Then, Wang *et al*. [@B32] performed a GWAS of ESCC by genotyping 1077 individuals with ESCC and 1733 control subjects of Han Chinese descent, and found that PLCE1 and C20orf54 play important roles for ESCC carcinogenesis. Wu *et al.* [@B33] performed a GWAS on 2031 ESCC individuals and 2044 controls of Chinese descent, and evaluated promising associations in an additional 6276 cases and 6165 controls from different areas of China. They identified five chromosomal regions (5q11, 6p21, 10q23, 12q24 and 21q22) that carried seven susceptibility loci for ESCC in the Chinese population, of which three (5q11, 6p21 and 21q22) were newly discovered [@B33]. Wu *et al.* [@B34] reported a multistage GWAS of ESCC in 10,123 ESCC cases and 10,664 controls. This GWAS identified nine new susceptibility loci for ESCC, of which seven (4q23, 16q12.1, 17q21, 22q12, 3q27, 17p13 and 18p11) had a significant marginal effect and two of which (2q22 and 13q33) had a significant association in the gene-alcohol interaction only [@B34]. Among 5337 Chinese with ESCC and 5787 controls (replication in 9654 Chinese with ESCC and 10,058 controls), Wu *et al*. [@B34] showed that rs7447927at 5q31.2 and rs1642764 at 17p13.1 were associated with ESCC susceptibility [@B34]. Furthermore, Hu *et al*. [@B39] showed that rs2274223 was associated with reduced PLCE1 expression and increased risk of ESCC. Another replication study by Wang *et al*. [@B40] showed that the ADH1B-ADH1C-ADH7 axis was modulated by the rs1042026, rs17033, rs1614972, rs1789903 and rs17028973 SNPs. In the present study, the identified polymorphisms matched those found by the previous studies, and included rs2294693 in 6p21.1, rs11059556 in 12q24, rs6854472 in 4q22, rs12922317 in 16p13.12, and rs9824873 in 3q28. The discrepancies among studies regarding the identified loci can be due to the genetic diversity among different regions of China and of the world. Additional studies are necessary to better understand the risk of ESCC.

The present study is not without limitations. Statistical correction was used to adjust for multiple testing for a specific gene, but this is controversial. The Bonferroni correction and Bayesian techniques are frequently used, but they are problematic when correcting multiple comparisons [@B41] and such corrections might not be needed when different associations are of interest on a purely one-at-a-time basis [@B42],[@B43]. Secondly, our study included patients with first ESCC and second ESCC. First ESCC is more relevant to genetic factors than second ESCC. Thirdly, although our study suggested that some loci may be involved in the prevalence of acquired ESCC, only selected SNPs based on the literature were examined and they might not be enough to describe the entire genetic variation of Han Chinese. Finally, this was a retrospective study and data about lifestyle habits (especially smoking and drinking) were not available or reliable for all patients, preventing subgroup and interaction analyses. Beyond the association studies, the literature is currently limited by the lack of mechanistic studies about the involvement of these SNPs in the development of ESCC and the present study was not designed to determine those mechanisms. Additional studies will have to be carried out on this issue.

Conclusion
==========

This large-scale replication study showed that rs12188136 and rs6854472 are associated with ESCC in a Han Chinese subgroup from Eastern China, and that rs875339 is negative associated with ESCC. This study underlines the genetic complexity of ESCC development.
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###### 

Demographic characteristics of ESCC cases and controls used in the study

  Study          N      Age, mean (s.d.)   Sex, male (%)
  -------------- ------ ------------------ ---------------
  **Cases**      2280   57.0 (8.8)         64.6
  First ESCC     1900   57.0 (9.4)         64.5
  Second ESCC    380    56.8 (9.0)         64.7
  **Controls**   1900   56.4 (9.3)         64.5

###### 

Information about 24 validated SNPs.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene: locus and OMIM No.^a^    SNP_ID       Chromosome No.   Chromosome Position^b^   Reference allele   Effect allele   MAF^c^   P^g^    P value for HWE^h^ test   Genotyping call Rate (%)^i^           
  ------------------------------ ------------ ---------------- ------------------------ ------------------ --------------- -------- ------- ------------------------- ----------------------------- ------- -------
  SERINC2: 1p35.1 OMIN: 614549   rs4478858    1                31411078                 G                  A               0.200    0.196   0.213                     0.0592                        0.551   96.75

  1p13                           rs10881372   1                106210655                C                  T               0.163    0.196   0.187                     0.2864                        0.224   97.37

  1q31                           rs10801638   1                198002090                C                  T               0.349    0.302   0.304                     0.8751                        0.795   97.13

  2p22                           rs10173378   2                43119650                 A                  G               0.198    0.241   0.221                     0.0409                        0.600   97.18

  LYPD6: 2q23.2\                 rs888103     2                149370922                C                  T               0.128    0.115   0.119                     0.6138                        0.464   97.32
  OMIN: 613359                                                                                                                                                                                              

  BZW1: 2q33\                    rs3815501    2                200821399                G                  A               0.488    0.464   0.467                     0.8099                        0.448   97.15
  OMIN: N.A                                                                                                                                                                                                 

  2q36                           rs6717108    2                224696318                C                  T               0.444    0.444   0.449                     0.6156                        0.265   96.82

  UMPS: 3q21.2\                  rs10934685   3                124747673                C                  T               0.389    0.341   0.335                     0.5626                        0.677   96.65
  OMIN: 613891                                                                                                                                                                                              

  ITGB5: 3q21.2\                 rs6768588    3                124768488                A                  G               0.244    0.278   0.282                     0.7215                        0.475   96.60
  OMIN: 147561                                                                                                                                                                                              

  3q28                           rs9824873    3                183583986                T                  C               0.291    0.329   0.325                     0.7073                        0.928   96.17

  4q22                           rs6854472    4                89513521                 G                  T               0.085    0.072   0.084                     0.0477                        0.871   97.75

  5q35                           rs12188136   5                174407635                A                  G               0.256    0.296   0.305                     0.3698                        0.222   96.77

  UNC5CL: 6p21.1\                rs2294693    6                41037763                 T                  C               0.267    0.253   0.245                     0.4418                        0.074   97.13
  OMIN: N.A                                                                                                                                                                                                 

  6q27                           rs9364414    6                168171267                G                  A               0.360    0.376   0.387                     0.3088                        0.439   96.79

  10p12                          rs7916519    10               23177805                 G                  A               0.140    0.230   0.234                     0.6363                        0.929   97.01

  DYNC2H1: 11q22.3\              rs11225815   11               103469085                T                  C               0.233    0.255   0.248                     0.4884                        0.606   96.56
  OMIN: 603297                                                                                                                                                                                              

  11q22                          rs10895458   11               103547356                A                  C               0.133    0.113   0.101                     0.0938                        0.266   97.30

  OPCML: 11q25\                  rs4578395    11               133242868                T                  C               0.105    0.091   0.088                     0.7086                        0.252   96.82
  OMIN: 600632                                                                                                                                                                                              

  12q24.3                        rs11059556   12               128161518                C                  T               0.279    0.336   0.338                     0.8632                        0.826   96.41

  13q13                          rs2025245    13               37529440                 G                  A               0.354    0.381   0.364                     0.1169                        0.401   97.22

  GPC5: 13q31.3\                 rs9584006    13               92249673                 T                  G               0.372    0.422   0.406                     0.1536                        0.746   96.39
  OMIN: 602446                                                                                                                                                                                              

  FMN1: 15q13.3\                 rs347940     15               32885469                 A                  G               0.442    0.357   0.357                     0.9613                        0.553   95.96
  OMIN: 136535                                                                                                                                                                                              

  RORA: 15q22.2\                 rs875339     15               60803856                 C                  T               0.314    0.313   0.295                     0.0881                        0.024   97.01
  OMIN: 600825                                                                                                                                                                                              

  SNX29: 16p13.13-p13.12\        rs12922317   16               11983775                 G                  A               0.256    0.318   0.300                     0.0916                        0.369   96.82
  OMIN: N.A                                                                                                                                                                                                 
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**a.** OMIM, Online Mendelian Inheritance in Man (<http://www.ncbi.nlm.nih.gov/Omim>); **b.** SNP position in the NCBI dbSNP Build 38 database (<http://www.ncbi.nlm.nih.gov/SNP>); **c.** MAF, minor allele frequency, representing the frequency of effect allele; **d.** MAF for Chinese in the NCBI dbSNPs database; **e.** MAF for control group; **f.** MAF for esophageal cancer group; **g.** P value, which was conducted withχ^2^ test, for difference in allele distributions between esophageal cancer and control group; **h.** HWE, Hardy-Weinberg equilibrium in control group;**i**. The percentage of successful genotype calls.

###### 

Genotype frequencies of 24 validated SNPs among cases and control and their associations with esophageal cancer risk under co-dominant genetic model.

  Gene          SNP ID       Genotype   Case           Control   P (2 df)^a^   Logistic regression   P~trend~                                         
  ------------- ------------ ---------- ------ ------- --------- ------------- --------------------- ------------------------- ------------------- -- -------
  **SERINC2**   rs4478858    GG         1380   62.22             1185          64.90                 0.1732                    1.000 (reference)      0.061
                             GA         732    33.00             567           31.05                 1.109 (0.969-1.268)       0.133                  
                             AA         106    4.78              74            4.05                  1.230 (0.905-1.672)       0.186                  
                rs10881372   CC         1481   66.00             1172          64.18                 0.4701                    1.000 (reference)      0.282
                             CT         688    30.66             592           32.42                 0.920 (0.804-1.052)       0.221                  
                             TT         75     3.34              62            3.40                  0.957 (0.678-1.352)       0.804                  
                rs10801638   CC         1096   49.04             891           48.82                 0.7977                    1.000 (reference)      0.876
                             CT         920    41.16             765           41.92                 0.978 (0.858-1.114)       0.734                  
                             TT         219    9.80              169           9.26                  1.053 (0.846-1.312)       0.641                  
                rs10173378   AA         1341   60.16             1053          57.45                 0.1040                    1.000 (reference)      0.039
                             AG         789    35.40             678           36.99                 0.914 (0.802-1.041)       0.176                  
                             GG         99     4.44              102           5.56                  0.762 (0.571-1.017)       0.065                  
  **LYPD6**     rs888103     CC         1743   77.95             1432          78.17                 0.3918                    1.000 (reference)      0.615
                             CT         456    20.39             379           20.69                 0.988 (0.848-1.152)       0.882                  
                             TT         37     1.65              21            1.15                  1.448 (0.844-2.484)       0.179                  
  **BZW1**      rs3815501    GG         633    28.33             516           28.24                 0.8648                    1.000 (reference)      0.809
                             GA         1115   49.91             925           50.63                 0.983 (0.850-1.136)       0.813                  
                             AA         486    21.75             386           21.13                 1.026 (0.860-1.225)       0.773                  
                rs6717108    CC         689    30.94             575           31.59                 0.8831                    1.000 (reference)      0.620
                             CT         1075   48.27             875           48.08                 1.025 (0.889-1.182)       0.731                  
                             TT         463    20.79             370           20.33                 1.044 (0.876-1.245)       0.629                  
  **UMPS**      rs10934685   CC         972    43.82             787           43.19                 0.8142                    1.000 (reference)      0.560
                             CT         1006   45.36             827           45.39                 0.985 (0.864-1.123)       0.821                  
                             TT         240    10.82             208           11.42                 0.934 (0.759-1.150)       0.522                  
  **ITGB5**     rs6768588    AA         1139   51.19             939           51.79                 0.9298                    1.000 (reference)      0.719
                             AG         919    41.30             740           40.82                 1.024 (0.899-1.166)       0.722                  
                             GG         167    7.51              134           7.39                  1.027 (0.806-1.310)       0.827                  
                rs9824873    TT         1014   45.84             816           45.13                 0.9025                    1.000 (reference)      0.708
                             TC         960    43.40             796           44.03                 0.971 (0.851-1.107)       0.656                  
                             CC         238    10.76             196           10.84                 0.977 (0.792-1.206)       0.830                  
                rs6854472    GG         1884   83.92             1586          86.15                 0.1370                    1.000 (reference)      0.047
                             GT         347    15.46             246           13.36                 1.187 (0.995-1.417)       0.056                  
                             TT         14     0.62              9             0.49                  1.310 (0.565-3.033)       0.529                  
                rs12188136   AA         1050   47.36             917           50.16                 0.0493                    1.000 (reference)      0.367
                             AG         981    44.25             740           40.48                 **1.158 (1.016-1.319)**   **0.027**              
                             GG         186    8.39              171           9.35                  0.950 (0.758-1.191)       0.656                  
  **UNC5CL**    rs2294693    TT         1268   56.78             1035          56.65                 0.1972                    1.000 (reference)      0.445
                             TC         835    37.39             661           36.18                 1.031 (0.905-1.175)       0.647                  
                             CC         130    5.82              131           7.17                  0.810 (0.627-1.047)       0.107                  
                rs9364414    GG         818    36.83             718           39.34                 0.1831                    1.000 (reference)      0.307
                             GA         1086   48.90             841           46.08                 1.133 (0.991-1.297)       0.068                  
                             AA         317    14.27             266           14.58                 1.046 (0.864-1.267)       0.645                  
                rs7916519    GG         1306   58.62             1085          59.39                 0.8840                    1.000 (reference)      0.636
                             GA         801    35.95             645           35.30                 1.032 (0.905-1.176)       0.641                  
                             AA         121    5.43              97            5.31                  1.036 (0.784-1.370)       0.802                  
  **DYNC2H1**   rs11225815   TT         1265   56.73             999           55.32                 0.6251                    1.000 (reference)      0.488
                             TC         824    36.95             694           38.43                 0.938 (0.823-1.069)       0.334                  
                             CC         141    6.32              113           6.26                  0.985 (0.759-1.279)       0.912                  
                rs10895458   AA         1800   80.65             1450          79.02                 0.0916                    1.000 (reference)      0.094
                             AC         413    18.50             357           19.46                 0.932 (0.796-1.091)       0.381                  
                             CC         19     0.85              28            1.53                  **0.547 (0.304-0.983)**   **0.044**              
  **OPCML**     rs4578395    TT         1845   82.88             1501          82.43                 0.9295                    1.000 (reference)      0.705
                             TC         368    16.53             309           16.97                 0.969 (0.821-1.144)       0.709                  
                             CC         13     0.58              11            0.60                  0.961 (0.430-2.152)       0.924                  
                rs11059556   CC         961    43.29             799           44.14                 0.6764                    1.000 (reference)      0.863
                             CT         1016   45.77             804           44.42                 1.051 (0.921-1.199)       0.462                  
                             TT         243    10.95             207           11.44                 0.976 (0.793-1.201)       0.819                  
                rs2025245    GG         907    40.55             708           38.75                 0.2705                    1.000 (reference)      0.119
                             GA         1030   46.04             845           46.25                 0.951 (0.832-1.088)       0.467                  
                             AA         300    13.41             274           15.00                 0.855 (0.706-1.035)       0.107                  
  **GPC5**      rs9584006    TT         780    35.15             609           33.65                 0.3271                    1.000 (reference)      0.154
                             TG         1077   48.54             876           48.40                 0.960 (0.836-1.103)       0.563                  
                             GG         362    16.31             325           17.96                 0.870 (0.724-1.045)       0.136                  
  **FMN1**      rs347940     AA         911    41.00             745           41.64                 0.6201                    1.000 (reference)      0.961
                             AG         1037   46.67             810           45.28                 1.047 (0.916-1.196)       0.500                  
                             GG         274    12.33             234           13.08                 0.958 (0.784-1.169)       0.670                  
  **RORA**      rs875339     CC         1104   49.44             881           48.35                 0.0341                    1.000 (reference)      0.091
                             CT         939    42.05             742           40.72                 1.010 (0.886-1.151)       0.883                  
                             TT         190    8.51              199           10.92                 **0.762 (0.613-0.947)**   **0.014**              
  **SNX29**     rs12922317   GG         1090   49.05             841           46.08                 0.1695                    1.000 (reference)      0.091
                             GA         929    41.81             808           44.27                 0.887 (0.779-1.011)       0.072                  
                             AA         203    9.14              176           9.64                  0.890 (0.713-1.110)       0.301                  

**a.** Global P values \[2 degrees of freedom (df)\]: genotype frequencies in esophageal cancer and control group were compared using a χ^2^ test with 2 df. **b.** P values from unconditional logistic regression analyses.

###### 

Association analysis of 24 validated SNPs under dominant and recessive genetic model.

  Gene          SNP ID       Genetic model    Case        Control    Logistic regression^a^    
  ------------- ------------ ---------------- ----------- ---------- ------------------------- -----------
  **SERINC2**   rs4478858    (GA+AA) vs. GG   838/1380    641/1185   1.123 (0.987-1.277)       0.079
                             AA vs. (GG+GA)   106/2112    74/1752    1.188 (0.877-1.610)       0.265
                rs10881372   (CT+TT) vs. CC   763/1481    654/1172   0.923 (0.811-1.051)       0.227
                             TT vs. (CC+CT)   75/2169     62/1764    0.984 (0.699-1.385)       0.925
                rs10801638   (CT+TT) vs. CC   1139/1096   934/891    0.991 (0.876-1.122)       0.891
                             TT vs. (CC+CT)   219/2016    169/1656   1.064 (0.862-1.314)       0.562
                rs10173378   (AG+GG) vs. AA   888/1341    780/1053   0.894 (0.788-1.014)       0.080
                             GG vs. (AA+AG)   99/2130     102/1731   0.789 (0.594-1.048)       0.101
  **LYPD6**     rs888103     (CT+TT) vs. CC   493/1743    400/1432   1.013 (0.872-1.176)       0.870
                             TT vs. (CC+CT)   37/2199     21/1811    1.451 (0.846-2.488)       0.176
  **BZW1**      rs3815501    (GA+AA) vs. GG   1601/633    1311/516   0.995 (0.868-1.142)       0.948
                             AA vs. (GG+GA)   486/1748    386/1441   1.038 (0.893-1.207)       0.628
                rs6717108    (CT+TT) vs. CC   1538/689    1245/575   1.031 (0.902-1.178)       0.655
                             TT vs. (CC+CT)   463/1764    370/1450   1.029 (0.882-1.199)       0.718
  **UMPS**      rs10934685   (CT+TT) vs. CC   1246/972    1035/787   0.975 (0.860-1.105)       0.688
                             TT vs. (CC+CT)   240/1978    208/1614   0.942 (0.773-1.146)       0.549
  **ITGB5**     rs6768588    (AG+GG) vs. AA   1086/1139   874/939    1.024 (0.905-1.160)       0.704
                             GG vs. (AA+AG)   167/2058    134/1679   1.017 (0.803-1.288)       0.890
                rs9824873    (TC+CC) vs. TT   1198/1014   992/816    0.972 (0.858-1.101)       0.654
                             CC vs. (TT+TC)   238/1974    196/1612   0.992 (0.812-1.211)       0.934
                rs6854472    (GT+TT) vs. GG   361/1884    255/1586   **1.192 (1.002-1.418)**   **0.048**
                             TT vs. (GG+GT)   14/2231     9/1832     1.277 (0.552-2.958)       0.568
                rs12188136   (AG+GG) vs. AA   1167/1050   911/917    1.119 (0.988-1.266)       0.076
                             GG vs. (AA+AG)   186/2031    171/1657   0.887 (0.714-1.103)       0.282
  **UNC5CL**    rs2294693    (TC+CC) vs. TT   965/1268    792/1035   0.995 (0.878-1.127)       0.932
                             CC vs. (TT+TC)   130/2103    131/1696   0.800 (0.623-1.029)       0.082
                rs9364414    (GA+AA) vs. GG   1403/818    1107/718   1.112 (0.979-1.264)       0.101
                             AA vs. (GG+GA)   317/1904    266/1559   0.976 (0.818-1.164)       0.785
                rs7916519    (GA+AA) vs. GG   922/1306    742/1085   1.032 (0.910-1.171)       0.620
                             AA vs. (GG+GA)   121/2107    97/1730    1.024 (0.778-1.348)       0.864
  **DYNC2H1**   rs11225815   (TC+CC) vs. TT   965/1265    807/999    0.944 (0.833-1.070)       0.369
                             CC vs. (TT+TC)   141/2089    113/1693   1.011 (0.783-1.306)       0.932
                rs10895458   (AC+CC) vs. AA   432/1800    385/1450   0.904 (0.775-1.054)       0.198
                             CC vs. (AA+AC)   19/2213     28/1807    0.554 (0.308-0.995)       0.048
  **OPCML**     rs4578395    (TC+CC) vs. TT   381/1845    320/1501   0.969 (0.823-1.141)       0.702
                             CC vs. (TT+TC)   13/2213     11/1810    0.967 (0.432-2.163)       0.934
                rs11059556   (CT+TT) vs. CC   1259/961    1011/799   1.035 (0.914-1.173)       0.586
                             TT vs. (CC+CT)   243/1977    207/1603   0.952 (0.782-1.159)       0.623
                rs2025245    (GA+AA) vs. GG   1330/907    1119/708   0.928 (0.818-1.053)       0.245
                             AA vs. (GG+GA)   300/1937    274/1553   0.878 (0.736-1.048)       0.149
  **GPC5**      rs9584006    (TG+GG) vs. TT   1439/780    1201/609   0.935 (0.821-1.066)       0.318
                             GG vs. (TT+TG)   362/1857    325/1485   0.891 (0.756-1.050)       0.168
  **FMN1**      rs347940     (AG+GG) vs. AA   1311/911    1044/745   1.027 (0.905-1.165)       0.680
                             GG vs. (AA+AG)   274/1948    234/1555   0.935 (0.775-1.127)       0.479
  **RORA**      rs875339     (CT+TT) vs. CC   1129/1104   941/881    0.957 (0.846-1.084)       0.491
                             TT vs. (CC+CT)   190/2043    199/1623   **0.758 (0.615-0.935)**   **0.010**
  **SNX29**     rs12922317   (GA+AA) vs. GG   1132/1090   984/841    0.888 (0.784-1.005)       0.060
  **SERINC2**                AA vs. (GG+GA)   203/2019    176/1649   0.942 (0.762-1.165)       0.581

**a.** P values from unconditional logistic regression analyses.
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